Thomas R. Fritsche
JMI Laboratories
345 Beaver Kreek Centre
Suite A
North Liberty
USA
Name/email consistency: high
- Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections. Fritsche, T.R., Rhomberg, P.R., Sader, H.S., Jones, R.N. Antimicrob. Agents Chemother. (2008)
- Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006). Fritsche, T.R., Biedenbach, D.J., Jones, R.N. J. Chemother (2008)
- Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America. Fritsche, T.R., Castanheira, M., Miller, G.H., Jones, R.N., Armstrong, E.S. Antimicrob. Agents Chemother. (2008)
- Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. Fritsche, T.R., Rhomberg, P.R., Sader, H.S., Jones, R.N. J. Antimicrob. Chemother. (2008)
- In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus. Fritsche, T.R., Rhomberg, P.R., Sader, H.S., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2008)
- Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006). Fritsche, T.R., Sader, H.S., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2008)
- Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). Fritsche, T.R., Sader, H.S., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2007)
- Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms. Fritsche, T.R., Rennie, R.P., Goldstein, B.P., Jones, R.N. J. Clin. Microbiol. (2006)
- Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance. Fritsche, T.R., Sader, H.S., Cleeland, R., Jones, R.N. Antimicrob. Agents Chemother. (2005)
- Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Fritsche, T.R., Sader, H.S., Stilwell, M.G., Dowzicky, M.J., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2005)
- Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004). Fritsche, T.R., Sader, H.S., Stilwell, M.G., Dowzicky, M.J., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2005)
- Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates. Fritsche, T.R., Strabala, P.A., Sader, H.S., Dowzicky, M.J., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2005)
- Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus. Fritsche, T.R., Jones, R.N. J. Drugs. Dermatol (2005)
- Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003). Fritsche, T.R., Stilwell, M.G., Jones, R.N. Clin. Microbiol. Infect. (2005)
- Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase. Fritsche, T.R., Moet, G.J., Jones, R.N. Clin. Microbiol. Infect. (2004)
- Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002). Fritsche, T.R., Sader, H.S., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2003)
